Zhiwen Chen
No. 29 Gaotanyan Street
Shaping, 400038, China
Shaping, 400038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Added value of PHI in predicting lymph node invasion in prostate cancer: an external validation.
Journal: BMC urology
Published: April 28, 2026
Rezvilutamide plus docetaxel in chemotherapy-naive metastatic castration-resistant prostate cancer patients after progression on abiraterone: A multi-centre, open-label, phase II trial.
Journal: Clinical and translational medicine
Published: December 15, 2025
XPC Deficiency Activate Cisplatin-Mediated Autophagy in Bladder Cancer by Limiting Novel PHRF1-Mediated Ubiquitination of the p53 Protein.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 09, 2025
Intracorporeal versus extracorporeal urinary diversion during robotic radical cystectomy: outcomes from a large single-institutional study.
Journal: BMC urology
Published: February 19, 2025
SENP3 induced HADHA deSUMOylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation.
Journal: Cancer letters
Published: February 10, 2025
Intracorporeal versus extracorporeal neobladder in robot-assisted radical cystectomy: perioperative, oncological, and functional outcomes from a single-institutional experience.
Journal: World journal of urology
Published: June 09, 2024
Patient-reported outcomes of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer patients (CHART): a randomized, phase 3 study.
Journal: Signal transduction and targeted therapy
Published: June 05, 2024
The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries.
Journal: International journal of surgery (London, England)
Published: February 15, 2024
Feasibility analysis of arterial CT radiomics model to predict the risk of local and metastatic recurrence after radical cystectomy for bladder cancer.
Journal: Discover oncology
Published: July 18, 2023
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: June 27, 2022
Loss of EMP1 promotes the metastasis of human bladder cancer cells by promoting migration and conferring resistance to ferroptosis through activation of PPAR gamma signaling.
Journal: Free radical biology & medicine
Published: May 29, 2022
Last Updated: 09/26/2026